Refine by
Pharmaceutical Preparations In Drug Articles & Analysis
65 news found
Protheragen-ING has recently announced its ability to provide freeze-drying flash-release formulation development services to clients involved in drug discovery and development worldwide. Lyophilized flash-release formulations are advanced drug delivery systems that incorporate the benefits of both lyophilization and flash-release technologies. “Whether customers are trying to develop a ...
With the evolution of pharmaceutical industry over the past decades, compliance remains a key factor in bringing novel drugs to market. ...
In the ever-evolving landscape of pharmaceutical research and development, the demand for innovative and efficient drug discovery methods is more pressing than ever. At the forefront of this demanding field is Protheragen-ING AI-Pharma, a contract research and development biotechnology company, offering cutting-edge solutions to researchers through its AI-powered drug discovery and design ...
In a groundbreaking development in the field of pharmaceuticals, CD Formulation, a prominent drug formulation company, has announced the launch of Oral Thin Film Technology. This cutting-edge drug delivery system is poised to revolutionize medication administration, offering patients a more convenient and effective treatment method. Oral Thin Film Technology is a user-friendly drug delivery ...
CD Formulation has been dedicated to pharmaceutical advancements, showcasing immense expertise in the development and optimization of micro-reservoir controlled-release drug delivery systems. These innovative systems have revolutionized the way medications are administered, enhancing patient comfort and ensuring optimal therapeutic efficacy. Transdermal drug delivery systems are very popular ...
In the quest to develop safe and effective medicines, pharmaceutical companies rely on the precise combination of active pharmaceutical ingredients (APIs) and excipients. These crucial components play a pivotal role in the formulation of pharmaceutical drugs, ensuring optimal drug delivery and patient outcomes. Recently, CD Formulation released a comprehensive guide titled "Active Pharmaceutical ...
CD Genomics, a renowned leader in genomics and next-generation sequencing (NGS) applications, has unveiled its cutting-edge HLA typing solutions, revolutionizing immune profiling and transplantation compatibility assessment. The human leukocyte antigen (HLA) system plays a crucial role in immune regulation and determining transplantation compatibility. HLA typing, the process of identifying ...
CD ComputaBio, a reputable computational service provider in the field of biology, is dedicated to supporting research and trials by offering access to the latest software, technologies, and expertise at competitive prices and with fast turnaround times for researchers. Recently, the company introduced a series of state-of-the-art services in Drug Design and Computer-Aided Drug Design (CADD) with ...
Always at the forefront of innovation, CD Formulation, a U.S.-based chemical supplier, recently announced its commitment to providing the highest quality contact angle testing services for pharmaceutical excipients worldwide. "Meeting customer needs and exceeding customer expectations are always our long-term goals. We seize every opportunity to apply the latest science and technology to the ...
“The launch of PFCT services comes at a time when the pharmaceutical industry is under increased scrutiny for its drug development practices. In recent years, there have been numerous instances of pharmaceutical companies releasing drugs that were later found to be unsafe or ineffective,” the Chief further added. ...
CD Formulation, a leading food ingredients supplier, recently announced the launch of its upgraded lineup of acidity regulators, anticaking agents, and coating agents. These high-quality products are designed to improve the texture, taste, and appearance of various food products. Acidity RegulatorsCD Formulation's acidity regulators are designed to enhance the flavor and quality of food ...
Earlier this month, the management of CD Formulation announced the launch of active ingredients, antioxidants, and chelating chemicals for customers worldwide who are involved with cosmetic manufacturing and processing. These three types of chemicals are now available for use in the cosmetic industry as raw materials. The cosmetics market has expanded dramatically over the past few decades. Among ...
Equipped with a cGMP-compliant laboratory and state-of-the-art analytical instruments, CD Formulation’s seasoned research team is well-prepared to handle the most complicated drug analytical issues as a contract service organization. ...
Araris Biotech AG, a company pioneering antibody-drug conjugate (ADC)-linker technology, announced today that it has recruited Dr. Bernd Schlereth as Chief Development Officer (CDO). He brings with him more than 20 years of experience in pharmaceutical drug development. Between 2019 and 2021 Dr. Bernd Schlereth worked as Vice President Oncology Research at Molecular Partners AG. From 2013 to ...
As an expert in fields like drug formulation and pharmaceutical analysis, CD Formulation has made commendable achievements. ...
Cellworks Group Inc., a leader in Personalized Therapy Biosimulation, today announced the launch of its Precision Drug Development business units aimed at accelerating time-to-market for drug development and reviving previously studied but unapproved pharmaceutical assets through predictive biosimulation. ...
Skin care is now a routine daily procedure for the majority of people worldwide. There are varieties of cosmetic ingredients that could be used for manufacturing skin care products. Fairly recently, CD Formulation announced that it has newly released a new product line of active cosmetic ingredients for possible uses in skin care cosmetics, color cosmetics, topical pharmaceutical cosmetics, and ...
VANCOUVER, British Columbia, Nov. 21, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced the closing of its previously announced private placement with two healthcare-focused institutional investors ...
VANCOUVER, British Columbia, Nov. 18, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced that it has entered into a securities purchase agreement with two healthcare-focused institutional investors ...
Over the past decade, the CD Formulation’s expert team has made tireless efforts in the research and development of drug delivery systems, trying to improve the pharmacokinetics and pharmacodynamics of drugs. In order to achieve the optimal therapeutic effect, the required dose must be delivered at the target site at the appropriate time and rate. “We have developed various drug ...